Abstract. The primary structure of the human laminin M chain was determined from cDNA clones isolated from human placental libraries. The clones covered a total of 6,942 bp, with 49-bp encoding a 5' end untranslated region and 6,893-bp coding for a translated sequence. The complete human laminin M chain contains a 22-residue signal peptide and 3,088 residues of the mature M chain. The M chain has a domain structure similar to that of the human and mouse A chains.
M chain was determined from cDNA clones isolated from human placental libraries. The clones covered a total of 6,942 bp, with 49-bp encoding a 5' end untranslated region and 6,893-bp coding for a translated sequence. The complete human laminin M chain contains a 22-residue signal peptide and 3,088 residues of the mature M chain. The M chain has a domain structure similar to that of the human and mouse A chains. The homology between the two human laminin heavy chains is highest in the short arm region and lowest in the long arm helical domain I + II. Northern blot analysis of human fetal tissues showed that the M chain was expressed in most tissues such as cardiac muscle, pancreas, lung, spleen, kidney, adrenal gland, skin, testis, meninges, choroid plexus, and some other regions of the brain, but not in liver, thymus, and bone. In situ hybridization localized the expression of the M chain gene to cells of mesenchymal origin. In contrast, expression of the A chain was observed only in kidney, testis, neuroretina and some region of brain as determined by Northern analyses. Epithelial and endothelial cells were negative for both M and A chain gene transcripts. The gene for the human M chain (LAMM) was localized to chromosome 6q22~23.
AMININS are a family of large extracellular glycoproteins.
Laminin, initially isolated from the murine Engelbreth-Holm-Swarm (EHS) ~ tumor, was shown to be a heterotrimeric cross-shaped molecule containing one large A chain of 400 kD, and two smaller B1 and B2 chains of about 200-kD each (Timpl et al., 1979; Cooper et al., 1981) . Recent studies have revealed that several genetically distinct subunit chains and consequently several laminin isoforms exist. In addition to the EHS laminin chains, merosin (M chain) a homologue of the A chain (Leivo and Engvall, 1988; Ehrig et al., 1990) , s-laminin (S chain) a homologue of the B1 chain (Hunter et al., 1989) , and B2t, a truncated homologue of the B2 chain , have been characterized. Recently partial sequence of another B1 chain variant in avian eye was reported (O'Rear, 1992) . K-laminin and kalinin are laminin isoforms that are present in epithelial basement membranes. K-laminin contains the B1 and B2 chains and has a third 190-kD chain immunologically distinct from the A chain (Marinkovich et al., 1992b) . Kalinin has three subunits of which the largest one is immunologically related to one chain of K-laminin (Rousselle et al., 1991; Marinkovich et al., 1992a) . A new systematic nomenclature has been proposed for laminin by Engel et al. (1991) according to which the classical EHS chains are termed Ae, Ble, and B2e chains, the M chain is termed Am, the S chain is termed Bls, and the truncated B2 homologue B2t chain.
The complete amino acid sequence of the human, mouse
and Drosophila A, B1, and B2 chains (Sasaki et al., , 1988 Pikkarainen et al., 1987 Pikkarainen et al., , 1988 Montell et al., 1988 Montell et al., , 1989 Chi and Hui, 1989; Haaparanta et al., 1991; Nissinen et al., 1991; KuscheGullberg et al., 1992) , the rat S chain (Hunter et al., 1989) and the human B2t chain has been determined. All the laminin chains have a characteristic structure with distinct domains containing cysteine-rich repeats, globular regions and helical structures. The long arm of the molecule is formed by a triple coiled coil with a large globule at the end contributed to by the A type chain. The short arms contain globular domains separated by rigid rod-like domains containing several cysteine-rich repeats. The short arm of the A chain has three globular domains and three rodlike domains. The laminin M chain (merosin) was first identified as a protein present in basement membranes of trophoblasts, Schwann cells, and striated muscle (Leivo and Engvall, 1988) . The carboxyl terminal sequence of the M chain reported by Ehrig et al. (1990) showed high homology with the laminin A chain. Furthermore, the M polypeptide has a similar size as the A chain and associates with the same light chains. The whole molecule was shown to have a cross-like structure similar to that of laminin. A previously reported 300-kD mouse heart laminin chain is likely to represent a species homologue of the M chain (Paulsson and Saladin, 1989; Paulsson et al., 1991) .
The different laminin chains have been shown to have quite varying tissue distribution as determined by immunohistological studies and Northern and in situ hybridization analyses (Cooper and MacQueen, 1983; Boot-Handford, 1987; Kleinman et al., 1987; Klein et al., 1988 Klein et al., , 1990 Sanes et al., 1990; Ekblom et al., 1990; KiJcherer-Ehret et al., 1990 , Nissinen et al., 1991 . For example, the A and M chains on the one hand, and the B1 and S chains on the other, have been shown to be mutually exclusive. In placenta four different types of heterotrimers have been identified: A-B1-B2, A-S-B2, M-B1-B2, and M-S-B2 .
In vitro studies have indicated that laminin mediates a variety of biological functions such as stimulation of cell proliferation, cell adhesion, differentiation, and neurite outgrowth. The cellular activities are thought to be mediated by cell membrane receptors, many of which are members of the integrin family (Ruoslahti, 1991; Mecham, 1991; Hynes, 1992) . Laminin molecules can self-aggregate and form a protein meshwork which, together with the type IV collagen network, contributes to the basement membrane supramolecular structure (Yurchenco and Schnitty, 1990; Yurchenco et al., 1992) .
In the present study we have isolated cDNA clones providing the complete primary structure of the human laminin M chain. The gene was localized to 6q22~q23. Expression of the laminin M and A chains was shown to vary extensively between tissues as examined by Northern analyses and in situ hybridization.
Materials and Methods

Generation and Characterization of cDNA Clones
cDNA libraries were made from human placental poly(A) RNA. First, RNA was primed with primer ML-1 (nucleotide residues 6917-6942; see Fig. 2 ) made according to the previously published M chain sequence (Ehrig et al., 1990) . The cDNA was prepared with a cDNA synthesis kit (Amersham Int., Buckinghamshire, UK), purified and cloned into a ~.gtl0 vector (Promega, Madison, WI) using EcoRI/NotI adaptors (Pharmacia, Uppsala, Sweden), and packaged using the Packagene extract system (Promega). Two other primer extension libraries were prepared similarly using primers M-10 (nucleotide residues 4153-4167; see Fig. 2 ) and ML-5 (nucleotide residues 1028-1050; see Fig. 2 ). The first library was screened by using the previously characterized merosin cDNA (Ehrig et al., 1990) as probe. The 5' end 1.4-kb EcoRI fragment of clone MI-1 was used to screen the second extension library, and the third cDNA library was screened using a 1.3-kb NotI/AccI fragment of clone M10-22. To obtain clones for the 5' end of the M chain, ML-6 (nucleotides 706-731) primed cDNA was synthesized and EcoRI adaptors (Promega) were ligated to the cDNA. An EcoRI adapter primer and specific primers were used to amplify the 5' end of the cDNA by PCR. Purified cDNA clones and PCR products were subcloned into Bluescript II (Stratagene, La Jolla, CA) and sequenced from both strands using dideoxy sequencing (Sanger et al., 1977) .
Chromosomal Localization
Chromosomal assignment of the human laminin M chain gene (LAMM) was carried out using human-mouse somatic cell hybrids (Shows et al., 1982 (Shows et al., , 1984 and in situ hybridizations (Cherif et al., 1989; Fan et al., 1990) with the M10-22 cDNA clone as probe.
Northern Analysts
Total RNA from 18-19-wk-old human fetal tissues was isolated and samples containing about 10 #g of each RNA were electrophoresed, transferred to a GeneScreen Plus filter and hybridized with human laminin A or M chain cDNA probes. For quantitative comparisons of expression between different tissues the amounts of RNA were standardized using signals obtained with a human 28S rRNA-specific probe as an internal standard. The autoradiographs were analyzed by an Image Quant laser scanner (Molecular Dynamics, Sunnyvale, CA).
In Situ Hybridization
To obtain sense and antisense probes for in situ hybridization a 260-bp NotISalI fragment from A chain cDNA clone C2-12 and a 350 bp XhoI-ClaI fragment from M chain cDNA clone MI-1 were cloned into the Bluescript II vector. Probes were labeled with 3SS-labeled UTP (Amersham Intl.) using T3 and T7 polymerases. Human fetal tissues from the 17th gestational week were used. In situ hybridization was performed essentially according to Cox et al. (1984) and Wilkinson and Green (1990) .
Results
Characterization of cDNA Clones and Amino Acid Sequence of the Laminin M Chain
A cDNA clone providing 1,130-amino acid residues from the carboxyl terminal end of the human M chain was reported by Ehrig et al. (1990) . This cDNA clone (MER 3') and its sequence were used for priming and screening of the first primer extension library. The longest positive 2.9-kb clone MI-1 (Fig. 1) was further characterized and its 5' end sequence was used to prime and screen the second primer extension library yielding clone M10-22 (3.2 kb). The 5' end of clone M10-22 was similarly used for screening of the third primer extension library resulting in the isolation of clone M5-1 (0.8 kb). Several libraries were made in order to obtain clones spanning the entire 5' end sequence. However, all clones obtained through those efforts were either of similar lengths or shorter than M5-1. Genomic clones that were characterized (data not shown) contained the putative exon 2, but not the coding region for the signal peptide and 5' untranslated region. The 5' end sequences were finally obtained by PCR amplification. The primer ML-6 was used to make cDNA to which EcoRI adaptors were ligated. An EcoRI adaptor primer and two specific primers were then used in PCR to amplify a 300-bp 5' end fragment, M6-16 (Fig. 1) , containing sequences for the 5' end untranslated region of the mRNA, the signal peptide and the amino terminal end of the M chain.
The nucleotide sequence of the overlapping cDNA clones and the deduced amino acid sequence are shown in Fig. 2 . The previously reported COOH-terminal end amino acid sequence (Ehrig et al., 1990 ) is also included. The clones generated and characterized in this study covered a total 6,942 bp, consisting of a 49-bp 5' end untranslated region and (Kozak, 1991) . The putative signal peptide contains 22-amino acids starting with the initiator methionine followed by a hydrophobic leucine-rich sequence. Computer program analysis predicting the signal peptidase cleavage site, based on the method of von Heijne (1986), suggested a cleavage site after Ala22, the mature human M chain thus starting with a glutamine residue as do most laminin chains. Altogether, the laminin M chain contains 3,088-amino acid residues after cleavage of the tentative 22-residue signal peptide.
Domain Structure of the Laminin M Chain and Comparison with the A Chain
The mature human M chain is 30 residues larger than the human A chain which contains 3,058 residues (Nissinen et al., 1991 , Haaparanta et al., 1991 . Comparison of the two sequences which are aligned in Fig. 3 demonstrates that the domain structure of the M chain is similar to that of the A chain, and that these two laminin heavy chains have considerable homology.
Domains VI (residues 23-386), IVb (residues 528-723), and IVa (residues 1,176-1,379) of the M chain are predicted to form globular structures. Domains V (residues 287-527), IIIb (residues 724-1,175), and IIIa (residues 1,380-1,573) contain cysteine-rich EGF-like repeats and are predicted to have rigid rod-like structures. The numbers of EGF-like repeats is identical in the M and A chains. Domain V has four and one-half repeats, domain IIIb has ten and one-half, and domain Ilia has four repeats. Beck et al. (1990 Beck et al. ( , 1992 count the half repeats as one, and according to that both chains contain 17-cysteine-rich repeats. Domains I + I I (residues 1,574-2,153), a part of which has previously been reported (Ehrig et al., 1990) , participates together with two B type chains in the formation of a triple coiled-coil structure that forms the long arm of the laminin molecule. In addition, the M chain contains one cysteine residue in this region which has no counterpart in the A chain or any of the B type chains characterized thus far. The large carboxyl-terminal G domain (residues 2,154-3,110) forms the large globule at the end of the long arm of the laminin molecule.
The amino-terminal domain VI in the M chain has 12, domain IVa two, domain IIIb one, domain I+II has 10 and domain G has 7-amino acid residues more than the A chain. Domain V in the A chain has two residues more than the corresponding domain in the M chain. Comparison of the amino acid sequences of the human laminin M and A chains shows that the overall sequence similarity is 46.6% (Table I) and 58.6% when conservative changes are included (Fig. 3) . The sequence identity is highest in the globular domains VI, or 73.9%, although this domain in the M chain contains 12 residues more at the amino-terminus than the A chain. If the additional glutamine rich amino-terminal sequence is excluded, the sequence similarity is 77.4%. All six cysteine sites in this domain are conserved. The amino acid sequence identities of the cysteine-rich domains V, IIIb, and IIIa between the M and A chains are 60.1, 54.9, and 50.2%, respectively. All cysteine residues in these domains are conserved and the length of domains are about the same. The globular domains IVb and IVa of the two chains also have approximately the same number of amino acids, although the sequence similarity is lower (42%). The sequence similarity between A and M chains is lowest in domains I+II or only 32.3 %. The sequence identity between domains G is 41.8 %. There are 28 putative N-glycosylation sites in the M chain and 34 in the A chain, 10 of these sites are conserved between the two chains. Most putative glycosylation sites are in domains G and I+II. It is noteworthy that the M chain does not contain an RGD sequence which is a recognition site for some integrins (Ruoslahti, 1991; Hynes, 1992) .
Chromosomal Assignment of the Human Laminin M Chain Gene (LAMM)
The human laminin M chain gene was mapped to chromosome 6 by hybridization of labeled cDNA clone M10-22 to DNA from a panel of 39 somatic cell hybrids. Hybridization clones together with the previously determined carboxyl terminal end amino acid sequence (Ehrig etal., 1990) . The putative signal peptidase cleavage site is indicated by a triangle. The cysteine residues are circled, and potential attachment sites for asparagine-linked oligosaccharides are boxed. This sequence data is available from EMBL/GenBank/DDBJ under accession number Z 26653 (LAMININM).
w Q S P S I K H G I E Y H Y V T I T L D L Q Q V F Q I A Y V I V K A A N S P R P G
of the M cDNA clone correlated with the distribution of chromosome 6 (data not shown). In situ hybridization of the cDNA to metaphase chromosomes confirmed the localization of the LAMM gene to chromosome 6, and more precisely to bands 6q22~q23 (Fig. 4) .
Expression of M and A Chain Genes in Human Tissues
Relative expression of the M and A chain genes was compared by Northern hybridization using RNA from several 18-19-wk-old human fetal tissues (Fig. 5 ) and a human 288 rRNA probe as internal standard (not shown). However, comparison of expression between the M and A chain genes was not possible due to different lengths and specific activity of the probes and different exposure times. As previously reported (Nissinen et al., 1991) , the A chain gene has highly restricted expression in human adult tissues.
Signals for the A chain were observed only in brain, meninges, neuroretina, kidney, and testis, while no signals were obtained with RNA from skin, colon, pancreas, adrenal glands, cardiac muscle, lung, thymus, spleen, liver, or calvarial bone, even after long exposures. The relative expression was highest in the neuroretina, and in the brain tissues the A chain gene is expressed in the intermediate zone, cerebellum, olfactory bulb, and weak expression was observed also in choroid plexus.
The M chain gene has a different expression pattern, signals being observed with RNA from most tissues studied except thymus, liver, calvarial bone, colon and ependymal, and intermediate zones of brain. The strongest expression of the M chain gene was seen in pancreas, choroid plexus, cardiac muscle, and meninges.
In Situ Hybridization
The location of M chain mRNA was analyzed by in situ hy- bridization in 17-wk-old human fetal tissues. A cell typespecific expression pattern for the M chain mRNA was obvious in kidney, heart, skin, and lung. In embryonic kidney, the transcripts for the M chain were predominantly found in the undifferentiated nephrogenic mesenchyme of the outermost cortex (Fig. 6, a and b) , whereas the nephric tubules and renal blood vessels remained negative. In heart muscle expression was observed in myocytes throughout the tissue (Fig. 6, c and d) . The epidermal cells of the skin did not express the M chain mRNA which, however, was abundant in the condensing mesenchyme around the tip of the developing hair follicles (Fig. 6, e and f) . In the lung (Fig. 6, g and h) label was found in the smooth muscle cells of the pulmonary arteria, while the alveolar and bronchiolar cells were negative. Thus, the epithelial and endothelial cells were negative for the M chain mRNA and the transcripts were found only in various mesenchymal cells. No cell-specific signals were observed with the A chain specific hybridizations in the tissues studied (data not shown).
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Discussion
The present results, together with the previously reported 3' end sequence ( 
Domain Structure
The domain structure of the M chain contains several fea- tures similar to other laminin chains and it is practically identical to that of the A chain. The amino terminal globular domains VI share the highest homology, although the M chain has additional 12 amino acids at the amino terminus. In fact, domain VI of all known human laminin chains (Pikkarainen et al., 1987 Nissinen et al., 1991) , the mouse A chain (Sasaki et al., 1988) , the rat S chain (Hunter et al., 1989) , and the Drosophila A chain (Kusche-Gullberg et al., 1992) can be aligned so that the cysteine residues, some glycine, serine, proline and arginine residues, and short amino acid sequences RP, TCG and WWQS match in all chains (Fig. 7) . A conserved sequence, Y(Y/F)Yxhxdhxh(G/R)G (h: hydrophobic residues, d: D, E, or N) (according to Beck et al., 1992) at the carboxyl terminus of domain VI is also found in the M chain. The function of these conserved sequences is not known, but they might have significance for the role of this domain in laminin self-assembly which is apparently mediated by the amino terminal globular domains (Yurchenco and Schnitty, 1990) . The number and order of the EGF-like repeats in domains V, IIIb, and IIIa are conserved in the human M chain and, generally, the repeats are very similar to the repeats present in the human and mouse A chains. The repeats in domain V of the human A, M, B1, B2, and B2t chains, the rat S chain, the murine A chain and the Drosophila A chain (Pikkarainen et al., 1987 Sasaki et al., 1988; Hunter et al., 1989; Nissinen et al., 1991; Kusche-Gullberg et al., 1992) can be aligned in order (Fig.  8) . The human B2t chain lacks the first EGF-like repeat, but the rest of the repeats match with repeats of the other chains. In contrast to other laminin chains, the Drosophila A chain contains 10 and a half EGFlike repeats in domain V (Kusche-Gullberg et al., 1992; MacKrell et al., 1993) . The two first cysteine-rich repeats in the Drosophila A chain can be aligned with repeats in the other chains but the rest of domain V differs more, although some similarities are found between repeats 3, 4, 5, and 6 in the Drosophila A chain and repeats 3, 4, and 5 in the other chains.
Globular domains IV of the A and B2 type chains have been suggested to have evolved by an insertion between the third and fourth cysteines in one EGF-like repeat, and to be duplicated in A chains to form domains IVb and IVa (Beck et al., 1990 . These domains are present in the M chain and are, thus, well conserved in the A type chains, except for the Drosophila A chain which contains only one domain IV. It also has another domain IV" that consists of duplicated sequences that are more similar to the Drosophila B1 chain domain IV (Kusche-Gullberg et al., 1992; MacKrell et al., 1993) . Domains I + II that form the long arm helical region are similar in the M and A chains and the cysteine pair that is suggested to form interchain disulfide bonds is conserved in the M chain. Domain G of the M chain consists of five internal repeats that contain 107-178-amino acid residues (Ehrig et al., 1990) . These repeats share 30 to 50% similarity when compared with the human or mouse A chain. The Drosophila A chain also has five repeats in the G domain, but there is a large spacer sequence rich in threonine residues between subdomains G3 and G4 (Kusche-Gullberg et al., 1992) . Several proteins are known to be homologous to the G domain in the A and M chains. For example, one domain of the HSPG (heparan sulfate proteoglycan) core protein, perlecan, has 33% similarity with the domain G of the human A and M chains . Other homologous proteins are sex hormone-binding globulin , androgen binding protein (Joseph and Baker, 1992) and neurexins (Ushkaryov et ai., 1992) . Also Drosophila proteins fat, slit, and crumbs share similarities with domain G of the M and A chains (Patthy, 1992) .
Expression of Laminin M and A Chains in Human Fetal Tissues
In the present study expression of the M chain gene was observed in many tissues known to contain the respective protein from immunohistologicai studies. However, the strong level of expression at an early embryonic stage contrasts previous immunostaining studies where the M chain was not detected in the mouse embryo (Leivo and Engvall, 1988) . The reason for this discrepancy is obscure, but it could be due to some unknown limitation in the antibodies or transcripts may not always be efficiently translated into proteins. The M chain has been reported to appear in mouse muscle tissues first after birth (Leivo and Engvall, 1988) and at adult stages also in some other tissues in several mammalian species . The in situ hybridization analyses localized the expression of the M chain gene to myocytes of heart muscle which agrees with several previous studies (Leivo and Engvall, 1988; Paulsson and Saladin, 1989; Klein et ai., 1990; Engvall et al., 1990; Paulsson et al., 1991) . However, expression was also seen in stromal cells close to condensing mesenchyme in kidney and skin. The M chain has been localized by a monoclonal antibody to a narrow region located between the stromal cells and pretubular condensates in the outer cortex. A good concordance be- Figure 8 . Alignment of domains V of the known human A-and B-type chains, the rat S chain, the mouse A chain and the Drosophila A chain. Amino acids that are identical in half of the chains are shaded, and dark shading indicates conserved change Phe (F)"--'Tyr (Y).
tween the M chain mRNA and protein expression is also seen in other embryonic tissues (Leivo, I., and H. Sariola, unpublished results) . The strong expression observed in mesenchymal cells located immediately beneath cells at the tip of the developing hair follicle and sebaceous glands indicates the potential role of the M chain in exocrine gland development. Expression of the M chain gene was not found in epithelial or endothelial cells of any of the tissues analyzed. Consequently, it can be concluded that during embryogenesis expression of the M chain is primarily, if not only, the property of cells of mesenchyme origin.
Expression of the A chain gene was shown to be considerably more restricted in human fetal tissues than that of the M chain gene. As previously reported for newborn human tissues (Nissinen et ai., 1991) Northern analysis revealed expression of the A chain gene in kidney. We could not locate the expression at this stage of kidney development to specific cells by in situ hybridizations. The A chain has been localized in the kidney to tubular and glomerular basement membranes of adult tissues and in polarized kidney epithelial cells (Holm et al., 1988; Klein et al., 1988; . Klein et al. (1990) reported the detection of A chain mRNA with poly(A) RNA from embryonic heart, liver, lung, intestine, and laminin containing the A chain has been isolated from skeletal and heart muscle, lung, liver, kidney, and intestine (Paulsson and Saladin, 1989) . However, in our studies on tissues from a 17-wk-old no signal for the A chain was observed with total RNA from in lung, heart, or liver, even after long exposures. This discrepancy could be due to in the types of RNAs used or due to differences in temporal expression during development. The intense expression of the A chain gene in neuroretina, olfactory bulbs, and cerebellum, is interesting and indicates its role in brain and nerve development as has been suggested in some previous reports (Edgar et al., 1984 (Edgar et al., , 1988 Sanes et al., 1990; Kleinman et al., 1990) . Detailed immunohistological and in situ hybridization analyses on developing brain tissues have been initiated to further analyze the temporal and spatial expression during brain development.
Several studies (Cooper and Mac Queen, 1983; BootHandford et al., 1987; Kleinman et al., 1987; Holm et ai., 1988; Klein et al., 1988; Engvall et ai., 1990; Sanes et al., 1990; Ekblom et ai., 1990; Kiicherer-Ehret et al., 1990; Nissinen et al., 1991; including the present study have demonstrated variability in both spatial and temporal expression of laminin subunit chains in vivo. 
